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Objective: Atrial fibrillation (AF) has been associated with dementia, even in patients without prior 
stroke and the pathogenesis that correlates the two entities is multifactorial. Imaging studies have 
shown that structural cerebral changes are common in patients with AF so it was thought that treat-
ment with oral anticoagulants should protect against small emboli which causes microinfarctions 
that eventually lead to cognitive deterioration. Patients with dementia are less likely to receive anti-
coagulant treatment although previous studies have reported that AF patients on anticoagulant treat-
ment at baseline had a 29% lower risk of dementia.1 To investigate prescription patterns of anticoagula-
tion therapy in patients with AF and dementia as well as incidence of dementia in the patient cohort.
Patients and Methods: A total of 1217 patients with non-valvular AF from two institutions were retro-
spectively evaluated. Physical examination, clinical history and medication profile were obtained at 
baseline. 
Results: Median age of our cohort was 71 years. A total of 162/1217 (13.3%) patients were diagnosed 
with dementia. Patients with dementia were significantly older, were more likely to be of female gen-
der, more likely to have diabetes mellitus, prior stroke/TIA, heart failure, peripheral artery disease, 
osteoporosis, thyroid disease, lower eGFR, lower height, lower weight, lower LVEF, lower hemoglobin, 
higher CRP, higher leukocytes, to take higher number of drugs in general and higher number of psychi-
atric drugs. Median follow-up of our cohort was 53 months. In univariate analyses among unselected 
AF patients, patients with dementia were significantly more likely to experience inferior overall sur-
vival (HR=15.3; P<0.001), shorter time to thrombosis (HR=8.4; P<0.001), shorter time to major bleeding 
(HR=4.13; P<0.001) and shorter time to first fall (HR=2.36; P<0.001).
Conclusion: Our findings speak in support of increased thrombotic and mortality risks in patients with 
dementia, possibly due to inadequate anticoagulation and higher number of comorbidities. Therefore, 
our suggestion is that physicians should prescribe more often DOACs in patients have dementia or 
higher risk of developing dementia. 
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